Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05159700 · ClinicalTrials.gov registry record · Phase 1

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor and Advanced Solid Malignancies, sponsored by Zhuhai Yufan Biotechnologies Co..

Active
Registry status
Phase 1
Development phase
39
Enrollment target
6
Study locations

NCT05159700 is a Phase 1 study of Advanced Solid Tumor and Advanced Solid Malignancies that is active but no longer recruiting, run by Zhuhai Yufan Biotechnologies Co.. The registered enrollment target is 39 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (80% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05159700, a Phase 1 study of Advanced Solid Tumor and Advanced Solid Malignancies, is active but no longer recruiting, sponsored by Zhuhai Yufan Biotechnologies Co..

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
39 participants
Enrollment target
6
Study locations

Study Summary

This is a Phase I, multicenter, open-label, 3+3 dose escalation study to determine the safety and preliminary efficacy of PRJ1-3024 in subjects with relapsed/refractory solid tumors.

Conditions Studied

Advanced Solid Tumor Advanced Solid Malignancies

Interventions

  • DRUG PRJ1-3024

Study Locations (6)

Texas

  • NEXT Oncology - Austin
  • Mays Cancer Center - San Antonio

Colorado

  • Sarah Cannon Research Institute at HealthONE - Denver

Florida

  • Sarah Cannon Research Institute at Florida Cancer Specialists - Orlando

Ohio

  • Christ Hospital - Cincinnati

Virginia

  • NEXT Oncology - Fairfax

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2022-03-31
Est. Completion 2026-06-29
Phase Phase 1

Sponsor

Zhuhai Yufan Biotechnologies Co.

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05159700

The ClinicalTrials.gov registry entry for NCT05159700 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (80% lower). The listed sponsor is Zhuhai Yufan Biotechnologies Co., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which PRJ1-3024 is the first listed.

NCT05159700 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Texas, Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT05159700 about?

NCT05159700 is a clinical study titled "A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors". This is a Phase I, multicenter, open-label, 3+3 dose escalation study to determine the safety and preliminary efficacy of PRJ1-3024 in subjects with relapsed/refractory solid tumors.

What is the current status of trial NCT05159700?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2022-03-31. Estimated completion is 2026-06-29.

What conditions does trial NCT05159700 study?

This clinical trial studies the following conditions: Advanced Solid Tumor, Advanced Solid Malignancies.

What interventions are being tested in trial NCT05159700?

The interventions under investigation include: PRJ1-3024 (DRUG).

Who is sponsoring clinical trial NCT05159700?

This trial is sponsored by Zhuhai Yufan Biotechnologies Co., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05159700 being conducted?

This trial has 6 study locations across Colorado, Florida, Ohio, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Advanced Solid Malignancies

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.